| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 23.7 | 626.8 | 359.8 | 22.3 | - | - | 1032.7 |
| 1 | - | - | - | - | 16.2 | 276.5 | 69.0 | 2.5 | - | - | 364.2 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 5.7 |
| 1 | 2.3 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | - |
| 1 | - |
| Number of post synapses: | 6196 |
| Number of pre synapses: | 2185 |
| Number of output connections: | 6684 |
| Coverage factor: | 1.9 |
| Columnar completeness: | 0.89 |
| Area completeness: | 0.95 |
| Cell size (columns): | 194 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#Cm28 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm4 (R) | Glu | 1,540 | 256.7 | 25.4% | 25.4% |
| 1 | MeTu3b (R) | ACh | 484 | 80.7 | 8.0% | 33.3% |
| 2 | Dm2 (R) | ACh | 453 | 75.5 | 7.5% | 40.8% |
| 3 | MeVP15 (R) | ACh | 336 | 56.0 | 5.5% | 46.3% |
| 4 | MeTu3c (R) | ACh | 335 | 55.8 | 5.5% | 51.9% |
| 5 | MeVPMe7 (L) | Glu | 334 | 55.7 | 5.5% | 57.4% |
| 6 | Tm5a (R) | ACh | 291 | 48.5 | 4.8% | 62.2% |
| 7 | MeVP14 (R) | ACh | 201 | 33.5 | 3.3% | 65.5% |
| 8 | MeLo3b (R) | ACh | 166 | 27.7 | 2.7% | 68.2% |
| 9 | Cm34 (R) | Glu | 139 | 23.2 | 2.3% | 70.5% |
| 10 | Mi15 (R) | ACh | 135 | 22.5 | 2.2% | 72.7% |
| 11 | MeVP1 (R) | ACh | 109 | 18.2 | 1.8% | 74.5% |
| 12 | MeTu2a (R) | ACh | 100 | 16.7 | 1.6% | 76.2% |
| 13 | Tm12 (R) | ACh | 91 | 15.2 | 1.5% | 77.7% |
| 14 | Cm18 (R) | Glu | 85 | 14.2 | 1.4% | 79.1% |
| 15 | MeLo5 (R) | ACh | 63 | 10.5 | 1.0% | 80.1% |
| 16 | MeLo6 (R) | ACh | 56 | 9.3 | 0.9% | 81.0% |
| 17 | MeVC27 (L) | unclear | 55 | 9.2 | 0.9% | 81.9% |
| 18 | Dm9 (R) | Glu | 53 | 8.8 | 0.9% | 82.8% |
| 19 | Cm10 (R) | GABA | 51 | 8.5 | 0.8% | 83.6% |
| 20 | MeVPMe7 (R) | Glu | 50 | 8.3 | 0.8% | 84.5% |
| 21 | Tm20 (R) | ACh | 39 | 6.5 | 0.6% | 85.1% |
| 22 | MeVPMe13 (R) | ACh | 37 | 6.2 | 0.6% | 85.7% |
| 23 | Cm33 (R) | GABA | 35 | 5.8 | 0.6% | 86.3% |
| 24 | Cm9 (R) | Glu | 28 | 4.7 | 0.5% | 86.8% |
| 25 | Dm-DRA1 (R) | Glu | 28 | 4.7 | 0.5% | 87.2% |
| 26 | MeVP12 (R) | ACh | 28 | 4.7 | 0.5% | 87.7% |
| 27 | Tm30 (R) | GABA | 26 | 4.3 | 0.4% | 88.1% |
| 28 | Cm2 (R) | ACh | 25 | 4.2 | 0.4% | 88.5% |
| 29 | Cm29 (R) | GABA | 23 | 3.8 | 0.4% | 88.9% |
| 30 | Cm26 (R) | Glu | 20 | 3.3 | 0.3% | 89.2% |
| 31 | Cm5 (R) | GABA | 20 | 3.3 | 0.3% | 89.6% |
| 32 | Tm5c (R) | Glu | 20 | 3.3 | 0.3% | 89.9% |
| 33 | Cm8 (R) | GABA | 19 | 3.2 | 0.3% | 90.2% |
| 34 | HBeyelet (R) | His | 18 | 3.0 | 0.3% | 90.5% |
| 35 | Tm34 (R) | Glu | 18 | 3.0 | 0.3% | 90.8% |
| 36 | MeVPMe10 (L) | Glu | 17 | 2.8 | 0.3% | 91.1% |
| 37 | Cm21 (R) | GABA | 16 | 2.7 | 0.3% | 91.3% |
| 38 | Cm7 (R) | Glu | 15 | 2.5 | 0.2% | 91.6% |
| 39 | TmY17 (R) | ACh | 15 | 2.5 | 0.2% | 91.8% |
| 40 | MeTu3a (R) | ACh | 14 | 2.3 | 0.2% | 92.1% |
| 41 | R7d (R) | His | 14 | 2.3 | 0.2% | 92.3% |
| 42 | Cm1 (R) | ACh | 13 | 2.2 | 0.2% | 92.5% |
| 43 | Cm3 (R) | GABA | 12 | 2.0 | 0.2% | 92.7% |
| 44 | aMe5 (R) | ACh | 11 | 1.8 | 0.2% | 92.9% |
| 45 | MeTu1 (R) | ACh | 11 | 1.8 | 0.2% | 93.1% |
| 46 | MeVP38 (R) | ACh | 11 | 1.8 | 0.2% | 93.2% |
| 47 | Cm14 (R) | GABA | 10 | 1.7 | 0.2% | 93.4% |
| 48 | Mi10 (R) | ACh | 10 | 1.7 | 0.2% | 93.6% |
| 49 | OA-AL2i4 (R) | OA | 10 | 1.7 | 0.2% | 93.7% |
| 50 | Cm6 (R) | GABA | 9 | 1.5 | 0.1% | 93.9% |
| 51 | MeTu2b (R) | unclear | 9 | 1.5 | 0.1% | 94.0% |
| 52 | MeVP6 (R) | Glu | 9 | 1.5 | 0.1% | 94.2% |
| 53 | Tm40 (R) | ACh | 9 | 1.5 | 0.1% | 94.3% |
| 54 | aMe9 (R) | ACh | 8 | 1.3 | 0.1% | 94.5% |
| 55 | MeVPLo2 (R) | ACh | 8 | 1.3 | 0.1% | 94.6% |
| 56 | MeVPMe12 (R) | ACh | 8 | 1.3 | 0.1% | 94.7% |
| 57 | aMe4 (R) | ACh | 7 | 1.2 | 0.1% | 94.8% |
| 58 | Cm11a (R) | ACh | 7 | 1.2 | 0.1% | 95.0% |
| 59 | Cm20 (R) | GABA | 7 | 1.2 | 0.1% | 95.1% |
| 60 | Pm4 (R) | GABA | 7 | 1.2 | 0.1% | 95.2% |
| 61 | Tm36 (R) | ACh | 7 | 1.2 | 0.1% | 95.3% |
| 62 | TmY10 (R) | ACh | 7 | 1.2 | 0.1% | 95.4% |
| 63 | TmY5a (R) | Glu | 7 | 1.2 | 0.1% | 95.5% |
| 64 | Cm15 (R) | GABA | 6 | 1.0 | 0.1% | 95.6% |
| 65 | Cm17 (R) | GABA | 6 | 1.0 | 0.1% | 95.7% |
| 66 | Dm8b (R) | Glu | 6 | 1.0 | 0.1% | 95.8% |
| 67 | MeTu4a (R) | ACh | 6 | 1.0 | 0.1% | 95.9% |
| 68 | MeVP10 (R) | ACh | 6 | 1.0 | 0.1% | 96.0% |
| 69 | MeVPMe13 (L) | ACh | 6 | 1.0 | 0.1% | 96.1% |
| 70 | Tm29 (R) | Glu | 6 | 1.0 | 0.1% | 96.2% |
| 71 | Tm5b (R) | ACh | 6 | 1.0 | 0.1% | 96.3% |
| instance | NT | total connections | connections /#Cm28 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Cm11b (R) | ACh | 911 | 151.8 | 13.5% | 13.5% |
| 1 | TmY10 (R) | ACh | 552 | 92.0 | 8.2% | 21.7% |
| 2 | Cm11a (R) | ACh | 515 | 85.8 | 7.6% | 29.3% |
| 3 | MeVPMe13 (R) | ACh | 357 | 59.5 | 5.3% | 34.6% |
| 4 | Cm7 (R) | Glu | 318 | 53.0 | 4.7% | 39.3% |
| 5 | Cm26 (R) | Glu | 267 | 44.5 | 4.0% | 43.3% |
| 6 | Cm11c (R) | ACh | 266 | 44.3 | 3.9% | 47.2% |
| 7 | Cm32 (R) | GABA | 213 | 35.5 | 3.2% | 50.3% |
| 8 | Tm5a (R) | ACh | 199 | 33.2 | 2.9% | 53.3% |
| 9 | Tm12 (R) | ACh | 191 | 31.8 | 2.8% | 56.1% |
| 10 | Cm29 (R) | GABA | 160 | 26.7 | 2.4% | 58.5% |
| 11 | aMe4 (R) | ACh | 149 | 24.8 | 2.2% | 60.7% |
| 12 | MeTu2b (R) | unclear | 149 | 24.8 | 2.2% | 62.9% |
| 13 | Cm11d (R) | ACh | 147 | 24.5 | 2.2% | 65.1% |
| 14 | Cm21 (R) | GABA | 143 | 23.8 | 2.1% | 67.2% |
| 15 | MeVP15 (R) | ACh | 135 | 22.5 | 2.0% | 69.2% |
| 16 | MeVPMe13 (L) | ACh | 124 | 20.7 | 1.8% | 71.0% |
| 17 | Cm17 (R) | GABA | 98 | 16.3 | 1.5% | 72.5% |
| 18 | Cm18 (R) | Glu | 79 | 13.2 | 1.2% | 73.7% |
| 19 | MeTu3c (R) | ACh | 76 | 12.7 | 1.1% | 74.8% |
| 20 | Cm15 (R) | GABA | 68 | 11.3 | 1.0% | 75.8% |
| 21 | Cm5 (R) | GABA | 68 | 11.3 | 1.0% | 76.8% |
| 22 | Cm33 (R) | GABA | 64 | 10.7 | 0.9% | 77.8% |
| 23 | Cm3 (R) | GABA | 58 | 9.7 | 0.9% | 78.6% |
| 24 | Cm4 (R) | Glu | 55 | 9.2 | 0.8% | 79.4% |
| 25 | TmY17 (R) | ACh | 52 | 8.7 | 0.8% | 80.2% |
| 26 | Cm-DRA (R) | ACh | 51 | 8.5 | 0.8% | 81.0% |
| 27 | Tm5b (R) | ACh | 51 | 8.5 | 0.8% | 81.7% |
| 28 | MeVP7 (R) | ACh | 50 | 8.3 | 0.7% | 82.4% |
| 29 | Dm8b (R) | Glu | 44 | 7.3 | 0.7% | 83.1% |
| 30 | Cm19 (R) | GABA | 42 | 7.0 | 0.6% | 83.7% |
| 31 | Tm20 (R) | ACh | 39 | 6.5 | 0.6% | 84.3% |
| 32 | Cm10 (R) | GABA | 34 | 5.7 | 0.5% | 84.8% |
| 33 | TmY21 (R) | ACh | 34 | 5.7 | 0.5% | 85.3% |
| 34 | Cm2 (R) | ACh | 31 | 5.2 | 0.5% | 85.8% |
| 35 | Dm20 (R) | Glu | 29 | 4.8 | 0.4% | 86.2% |
| 36 | Cm8 (R) | GABA | 28 | 4.7 | 0.4% | 86.6% |
| 37 | l-LNv (R) | unclear | 28 | 4.7 | 0.4% | 87.0% |
| 38 | Tm5c (R) | Glu | 28 | 4.7 | 0.4% | 87.4% |
| 39 | Dm-DRA1 (R) | Glu | 25 | 4.2 | 0.4% | 87.8% |
| 40 | Cm1 (R) | ACh | 24 | 4.0 | 0.4% | 88.2% |
| 41 | Cm31b (R) | GABA | 24 | 4.0 | 0.4% | 88.5% |
| 42 | Dm2 (R) | ACh | 22 | 3.7 | 0.3% | 88.8% |
| 43 | Tm5Y (R) | ACh | 22 | 3.7 | 0.3% | 89.2% |
| 44 | MeTu3b (R) | ACh | 21 | 3.5 | 0.3% | 89.5% |
| 45 | aMe2 (R) | Glu | 20 | 3.3 | 0.3% | 89.8% |
| 46 | MeTu2a (R) | ACh | 19 | 3.2 | 0.3% | 90.1% |
| 47 | Tm29 (R) | Glu | 18 | 3.0 | 0.3% | 90.3% |
| 48 | Tm33 (R) | ACh | 18 | 3.0 | 0.3% | 90.6% |
| 49 | Mi15 (R) | ACh | 16 | 2.7 | 0.2% | 90.8% |
| 50 | Cm34 (R) | Glu | 15 | 2.5 | 0.2% | 91.1% |
| 51 | MeVP12 (R) | ACh | 15 | 2.5 | 0.2% | 91.3% |
| 52 | MeVPMe7 (L) | Glu | 15 | 2.5 | 0.2% | 91.5% |
| 53 | Cm9 (R) | Glu | 14 | 2.3 | 0.2% | 91.7% |
| 54 | Tm40 (R) | ACh | 14 | 2.3 | 0.2% | 91.9% |
| 55 | Cm14 (R) | GABA | 12 | 2.0 | 0.2% | 92.1% |
| 56 | Cm24 (R) | Glu | 12 | 2.0 | 0.2% | 92.3% |
| 57 | Cm6 (R) | GABA | 12 | 2.0 | 0.2% | 92.4% |
| 58 | MeVP1 (R) | ACh | 12 | 2.0 | 0.2% | 92.6% |
| 59 | TmY18 (R) | ACh | 12 | 2.0 | 0.2% | 92.8% |
| 60 | Cm31a (R) | GABA | 11 | 1.8 | 0.2% | 93.0% |
| 61 | MeVP40 (R) | unclear | 11 | 1.8 | 0.2% | 93.1% |
| 62 | aMe5 (R) | ACh | 10 | 1.7 | 0.1% | 93.3% |
| 63 | MeTu3a (R) | ACh | 10 | 1.7 | 0.1% | 93.4% |
| 64 | MeVP2 (R) | ACh | 10 | 1.7 | 0.1% | 93.6% |
| 65 | MeVP47 (R) | unclear | 10 | 1.7 | 0.1% | 93.7% |
| 66 | MeVP6 (R) | Glu | 10 | 1.7 | 0.1% | 93.9% |
| 67 | Mi17 (R) | GABA | 10 | 1.7 | 0.1% | 94.0% |
| 68 | Tm37 (R) | Glu | 10 | 1.7 | 0.1% | 94.2% |
| 69 | aMe12 (R) | ACh | 9 | 1.5 | 0.1% | 94.3% |
| 70 | Cm20 (R) | GABA | 9 | 1.5 | 0.1% | 94.4% |
| 71 | Dm8a (R) | Glu | 9 | 1.5 | 0.1% | 94.6% |
| 72 | MeLo3b (R) | ACh | 9 | 1.5 | 0.1% | 94.7% |
| 73 | MeTu1 (R) | ACh | 9 | 1.5 | 0.1% | 94.8% |
| 74 | MeVPLo2 (R) | ACh | 9 | 1.5 | 0.1% | 95.0% |
| 75 | Mi16 (R) | GABA | 9 | 1.5 | 0.1% | 95.1% |
| 76 | Mi2 (R) | Glu | 9 | 1.5 | 0.1% | 95.2% |
| 77 | Tm31 (R) | Glu | 9 | 1.5 | 0.1% | 95.4% |
| 78 | Tm38 (R) | ACh | 9 | 1.5 | 0.1% | 95.5% |
| 79 | aMe9 (R) | ACh | 8 | 1.3 | 0.1% | 95.6% |
| 80 | Tm39 (R) | ACh | 8 | 1.3 | 0.1% | 95.7% |
| 81 | TmY5a (R) | Glu | 8 | 1.3 | 0.1% | 95.9% |
| 82 | Dm9 (R) | Glu | 7 | 1.2 | 0.1% | 96.0% |
| 83 | ME_unclear (R) | ACh | 7 | 1.2 | 0.1% | 96.1% |
| 84 | MeVP10 (R) | ACh | 7 | 1.2 | 0.1% | 96.2% |
| 85 | MeVPMe3 (R) | Glu | 7 | 1.2 | 0.1% | 96.3% |
| 86 | Tm3 (R) | ACh | 7 | 1.2 | 0.1% | 96.4% |
| 87 | Cm13 (R) | Glu | 6 | 1.0 | 0.1% | 96.5% |
| 88 | Cm22 (R) | GABA | 6 | 1.0 | 0.1% | 96.5% |
| 89 | Tm34 (R) | Glu | 6 | 1.0 | 0.1% | 96.6% |